AstraZeneca reaffirms Covid vaccine safety amid rare TTS concerns

In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its commitment to patient safety while......

At $84 bn, India ranks fourth in 2023 military spend: SIPRI report

India was the fourth largest military spender globally in 2023 with an expenditure of $83.6 billion, behind the US, China and Russia, according to a report by an independent international......

Cong slams India's envoy to Ireland for criticising party

The Congress on Tuesday took strong objection to the criticism directed at it by the Indian envoy to Ireland while responding to an Irish daily's editorial, saying that attacking opposition parties......

'You are ruining an entire generation'

'We are calling companies to set up assembly plants for mobile phones while all the components are imported.''Only the last turn of the screwdriver is done here. And you call it self-reliance,......

Sensex tanks 455 points dragged by bank stocks

Equity benchmark indices Sensex and Nifty faced heavy volatility on Thursday and ended lower, taking their losing streak to the fourth straight session, dragged by bank stocks and foreign fund......

With oil on the boil, Vistara's loss may not be IndiGo's gain

Shares of low-cost airline IndiGo hit record high on the bourses soon after reports of pilot crisis at Vistara emerged. Photograph: Vivek Prakash/Reuters The development also saw airfares surge......

Nifty cos' profit growth seen at slowest in 5 qtrs

The brokerage earnings estimate for the January-March 2024 quarter (Q4FY24) for Nifty 50 companies hints at a slowdown in corporate profit growth while revenue increase is likely to be in low......

FY24: A Rewarding Year For IPO Investors

Eighty per cent, or 60 of the 75 companies that made their debut on the mainboard this financial year, ended their listing day with gains. Illustration: Dominic Xavier/Rediff.com Financial year......